Edwards Lifesciences Corp (USD)
EW
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range229.10 | 234.05
52-Wk Range163.08 | 247.64
Last Close230.45
Mkt Cap (m)48,064.96
Dividend yield-
ISINUS28176E1082
Volume1,670,309
Exchange VenueNYS

Company Profile

Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.

Key Information
Price/Earning63.14
Price/Book12.59
Price/Sales11.77
P/CF45.55
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 07/06/2018
Annual Report
en 31/12/2018

Financials

Income Statement
USD201420152016201720182019
Revenue (m)2,3232,4942,9643,4353,723-
Operating Income (m)4836437841,0231,073-
Net Income (m)811495570584722-
Basic EPS3.812.302.672.773.45-
Avg. Diluted Shares Outstanding (m)217220218216214-
Balance Sheet
USD201420152016201720182019
Current Assets (m)2,2952,0482,2402,5322,287-
Non Current Assets (m)1,2302,0112,2703,1643,037-
Total Assets (m)3,5244,0594,5105,6965,324-
Current Liabilities (m)4344765331,403877-
Total Liabilities (m)------
Total Equity (m)2,1912,5032,6192,9563,140-
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)1,0225507041,001927-
Capital Expenditure (m)-94-107-217-176-242-
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
230.45
Last Price